AUA
  • Program
  • Register
  • Meeting Coverage
  • Guidelines
  • Industry Highlights
  • Science & Technology Hall
  • Photo Gallery
Topics
  • Meeting Coverage
  • Guidelines
  • Industry Highlights
  • Science & Technology Hall
  • Photo Gallery
Resources
  • Program
  • Register
Twitter X icon Facebook iconInstagram iconYouTube iconLinkedIn icon
Apr 26, 2025

Precision medicine brings new focus to prostate cancer treatment

Enhancing diagnostic accuracy to improve patient outcomes.


From left, top to bottom: Drs. Adam Kibel, Robert Reiter, Steven Rowe and Evan Yu
From left, top to bottom: Drs. Adam Kibel, Robert Reiter, Steven Rowe and Evan Yu

As prostate cancer care continues to evolve, cutting-edge imaging and biomarker technologies are rapidly reshaping clinical decision-making by improving diagnostic accuracy and, ultimately, leading to more personalized approaches to care.

“Biomarkers and PSMA imaging are central to the management of all stages of prostate cancer, from newly diagnosed disease to metastatic,” said Adam Kibel, MD, one of the presenters in today’s session, “Integration of Biomarkers, MRI and PSMA PET Imaging Into the Management of Prostate Cancer,” 2-4 p.m. in Venetian H. “Our session will ensure that providers fully understand how to use these critical tools to optimize patient care.”

Dr. Kibel, chair of urology at Mass General Brigham in Boston and the Elliot Carr Cutler Professor of Surgery at Harvard Medical School, will join Evan Yu, MD, section head of medical oncology at Fred Hutchinson Cancer Center, Robert Reiter, MD, Bing Professor of Urologic Oncology and chief of the urologic oncology division at UCLA, and Steven Rowe, MD, PhD, assistant professor in the Russell H. Morgan Department of Radiology and Radiological Science at Johns Hopkins, for this CME-accredited session offering an in-depth exploration into how these tools are transforming diagnosis, staging and treatment selection for patients across the disease spectrum.

During this session, participants will gain practical insights into determining the right clinical scenarios for deploying PSMA PET/CT, recognizing its strengths and limitations and translating imaging findings into tailored therapeutic plans. With recent studies highlighting the sensitivity and specificity of PSMA-targeted imaging, this session arrives at a crucial time for clinicians looking to enhance diagnostic accuracy and improve patient outcomes.

In addition to PSMA imaging, the session will cover emerging biomarkers and how they contribute to more precise staging, recurrence detection and treatment monitoring.

Presenters will also define patient selection strategies for those with radio-recurrent and organ-confined prostate cancer—helping urologists identify candidates most likely to benefit from advanced imaging techniques.

With leading experts and practical insights, this session is a must-attend for clinicians aiming to stay at the forefront of prostate cancer care. Whether managing early-stage disease or guiding advanced cases, the knowledge shared here will directly impact your ability to deliver more precise, personalized treatment.

Interesting Stories
Book your AUA2025 housing now
Sponsored by AUA
Book your AUA2025 housing now
YONSA® (abiraterone acetate) Holds a Full House of Benefits—See Booth 1222
Sponsored by Sun Pharma
YONSA® (abiraterone acetate) Holds a Full House of Benefits—See Booth 1222
Register for the Career Fair at AUA2025
Sponsored by AUA
Register for the Career Fair at AUA2025
More Content
Getty Images 2212620732
Meeting Coverage
Thought-provoking takeaways from AUA2025
Jun 02, 2025
Getty Images 1203616323
Guidelines
Guidelines offer new directions in urological care
Jun 02, 2025
Getty Images 1397381715
Meeting Coverage
P2s at AUA2025: Clinical trials reshaping urology
Jun 02, 2025
Vin Gupta, MD, MPA
Meeting Coverage
Keynote call to action: Rethinking innovation in urology
Jun 02, 2025
K4 0795
Meeting Coverage
Meet your 2025 AUA Residents Bowl champions!
Jun 02, 2025
Siobhan Hartigan, MD
Meeting Coverage
Healthy debates
Jun 02, 2025
Dr. David Penson (fourth from left) and first-place winner (small program) Cedars-Sinai Urology Residency Program.
Meeting Coverage
Olympic gold
Jun 02, 2025
Mg 1067 is0 U4 Ai31z Copy
Meeting Coverage
Picture this
Jun 02, 2025
Getty Images 1356620786
Meeting Coverage
Save the date for AUA2026
Jun 02, 2025
Aua Readit xd2d B Aih Gz Copy
Meeting Coverage
Did you miss something?
Jun 02, 2025
Getty Images 1285476518
Meeting Coverage
AUA2025: By the numbers
May 13, 2025
Getty Images 2196976767
Meeting Coverage
Claim your CME
May 13, 2025
AUA
Twitter X icon Facebook iconInstagram iconYouTube iconLinkedIn icon
© 2025 Ascend Media. All rights reserved.